The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2-Reference-Cited by-同舟云学术

The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2

Published:2015-03-26 Issue:13 Volume:6 Page:10853-10867
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Skrypek Nicolas¹²³,Vasseur Romain¹²³,Vincent Audrey¹²³,Duchêne Bélinda¹²³,Van Seuningen Isabelle¹²³,Jonckheere Nicolas¹²³

Affiliation:

1. Inserm, UMR-S1172, Jean Pierre Aubert Research Center, Team #5 “Mucins, epithelial differentiation and carcinogenesis”, Lille cedex 59045, France

2. Université Lille Nord de France, Lille cedex 59000, France

3. Centre Hospitalier Régional et Universitaire de Lille, Lille cedex 59037, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the Mechanism of Curculiginis Rhizoma in Suppressing Cisplatin Resistance in Non-Small Cell Lung Cancer: An Experimental Study;OncoTargets and Therapy;2024-06

2. DNA methylation‐associated allelic inactivation regulates Keratin 19 gene expression during pancreatic development and carcinogenesis;The Journal of Pathology;2023-08-09

3. Prior irinotecan exposure does not preclude benefit to liposomal irinotecan in patients with metastatic pancreatic ductal adenocarcinoma;Cancer Medicine;2023-03-19

4. Role of Intracellular and Extracellular Annexin A1 in MIA PaCa-2 Spheroids Formation and Drug Sensitivity;Cancers;2022-09-29

5. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment;Nature Genetics;2022-07-28